https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-phase-iia-study-results-for-a-new-first-in-class-candidate-medicine/
Results demonstrate the potential for this asset to be a component of simpler TB treatment regimens in the future.
phase iiaresults forgskannouncespositive
https://www.news-medical.net/news/20100415/Phase-IIa-clinical-trial-results-of-Serdaxin-for-treatment-of-MDD.aspx
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics,...
phase iiaclinical trialresultsserdaxintreatment
https://www.technologynetworks.com/genomics/news/evolva-receives-clearance-to-move-ev077-into-phase-iia-193879
Regulatory clearance to progress EV-077 into Phase IIa for the treatment of diabetic complications.
phase iiaevolvareceivesclearancemove